Korrektur
Correction to “ MMP9 Knockout by CRISPR ‐Cas9 Reduces Bladder Cancer Malignancy But Does Not Synergize With BCG and Anti‐ PD ‐ L1 in an Orthotopic Mouse Model”
IUBMB Life · 2026-10 · 78 (10)
DOI: 10.1002/iub.70134 ↗Kurz gefasst
Korrektur in der Zeitschrift IUBMB Life, online erschienen am 09.10.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “ MMP9 Knockout by CRISPR ‐Cas9 Reduces Bladder Cancer Malignancy But Does Not Synergize With BCG and Anti‐ PD ‐ L1 in an Orthotopic Mouse Model”. IUBMB Life, 78(10). https://doi.org/10.1002/iub.70134
Vancouver
Correction to “ MMP9 Knockout by CRISPR ‐Cas9 Reduces Bladder Cancer Malignancy But Does Not Synergize With BCG and Anti‐ PD ‐ L1 in an Orthotopic Mouse Model”. IUBMB Life. 2026;78(10). doi:10.1002/iub.70134
BibTeX
@article{euvimed2026,
title = {Correction to “ MMP9 Knockout by CRISPR ‐Cas9 Reduces Bladder Cancer Malignancy But Does Not Synergize With BCG and Anti‐ PD ‐ L1 in an Orthotopic Mouse Model”},
journal = {IUBMB Life},
year = {2026},
volume = {78},
number = {10},
doi = {10.1002/iub.70134}
}
EUVIMED